Related Experiment Video
Updated: Apr 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Dobutamine induced eosinophilic myocarditis and right heart failure requiring emergent biventricular assist device
Vikram P Raje1, Neil P Lewis, Gundars J Katlaps
1From the *Department of Internal Medicine, Division of Cardiovascular Disease, Virginia Commonwealth University, Richmond, Virginia; and †Hunter Holmes McGuire Veterans Medical Center, Richmond, Virginia.
Abstract:
Dobutamine is a rare and unrecognized cause of eosinophilic myocarditis (EM). It is even more unique for it to cause significant clinical deterioration. Patients with end stage cardiomyopathy have very little cardiac reserve and dobutamine induced myocarditis may cause enough harm to require urgent mechanical circulatory support. We describe a man with dilated cardiomyopathy that developed accelerated clinical deterioration from dobutamine induced EM. He had a predominance of right heart failure, requiring an urgent biventricular assist device and acutely responded to withdrawal of dobutamine.
More Related Videos
07:41Induction and Phenotyping of Acute Right Heart Failure in a Large Animal Model of Chronic Thromboembolic Pulmonary Hypertension
Published on: March 17, 2022
07:41Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
Published on: July 20, 2022
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis III: Medical Management